vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and Revolve Group, Inc. (RVLV). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $324.4M, roughly 1.5× Revolve Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 5.7%, a 1.1% gap on every dollar of revenue. On growth, Revolve Group, Inc. posted the faster year-over-year revenue change (10.4% vs -1.7%). Over the past eight quarters, Revolve Group, Inc.'s revenue compounded faster (9.5% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Revolve Theatre Company is a Henley-on-Thames based theatre company specialising in political and Shakespearean plays. The company is owned by Oliver Dench, Joe Morris and Tom Smith.
MD vs RVLV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $324.4M |
| Net Profit | $33.7M | $18.6M |
| Gross Margin | — | 53.3% |
| Operating Margin | 9.9% | 6.3% |
| Net Margin | 6.8% | 5.7% |
| Revenue YoY | -1.7% | 10.4% |
| Net Profit YoY | 10.5% | 50.4% |
| EPS (diluted) | $0.40 | $0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $324.4M | ||
| Q3 25 | $492.9M | $295.6M | ||
| Q2 25 | $468.8M | $309.0M | ||
| Q1 25 | $458.4M | $296.7M | ||
| Q4 24 | $502.4M | $293.7M | ||
| Q3 24 | $511.2M | $283.1M | ||
| Q2 24 | $504.3M | $282.5M | ||
| Q1 24 | $495.1M | $270.6M |
| Q4 25 | $33.7M | $18.6M | ||
| Q3 25 | $71.7M | $21.2M | ||
| Q2 25 | $39.3M | $10.2M | ||
| Q1 25 | $20.7M | $11.8M | ||
| Q4 24 | $30.5M | $12.3M | ||
| Q3 24 | $19.4M | $11.0M | ||
| Q2 24 | $-153.0M | $15.4M | ||
| Q1 24 | $4.0M | $10.9M |
| Q4 25 | — | 53.3% | ||
| Q3 25 | — | 54.6% | ||
| Q2 25 | — | 54.1% | ||
| Q1 25 | — | 52.0% | ||
| Q4 24 | — | 52.5% | ||
| Q3 24 | — | 51.2% | ||
| Q2 24 | — | 54.0% | ||
| Q1 24 | — | 52.3% |
| Q4 25 | 9.9% | 6.3% | ||
| Q3 25 | 13.8% | 7.1% | ||
| Q2 25 | 12.8% | 5.8% | ||
| Q1 25 | 7.0% | 5.0% | ||
| Q4 24 | 7.8% | 3.9% | ||
| Q3 24 | 6.6% | 5.0% | ||
| Q2 24 | -31.3% | 5.8% | ||
| Q1 24 | 3.2% | 3.4% |
| Q4 25 | 6.8% | 5.7% | ||
| Q3 25 | 14.5% | 7.2% | ||
| Q2 25 | 8.4% | 3.3% | ||
| Q1 25 | 4.5% | 4.0% | ||
| Q4 24 | 6.1% | 4.2% | ||
| Q3 24 | 3.8% | 3.9% | ||
| Q2 24 | -30.3% | 5.4% | ||
| Q1 24 | 0.8% | 4.0% |
| Q4 25 | $0.40 | $0.27 | ||
| Q3 25 | $0.84 | $0.29 | ||
| Q2 25 | $0.46 | $0.14 | ||
| Q1 25 | $0.24 | $0.16 | ||
| Q4 24 | $0.37 | $0.18 | ||
| Q3 24 | $0.23 | $0.15 | ||
| Q2 24 | $-1.84 | $0.21 | ||
| Q1 24 | $0.05 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $292.3M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $512.5M |
| Total Assets | $2.2B | $765.0M |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $292.3M | ||
| Q3 25 | $340.1M | $315.4M | ||
| Q2 25 | $224.7M | $310.7M | ||
| Q1 25 | $99.0M | $300.8M | ||
| Q4 24 | $229.9M | $256.6M | ||
| Q3 24 | $103.8M | $252.8M | ||
| Q2 24 | $19.4M | $244.7M | ||
| Q1 24 | $8.0M | $273.4M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $512.5M | ||
| Q3 25 | $890.7M | $490.2M | ||
| Q2 25 | $833.8M | $468.6M | ||
| Q1 25 | $789.2M | $453.4M | ||
| Q4 24 | $764.9M | $437.8M | ||
| Q3 24 | $732.5M | $420.8M | ||
| Q2 24 | $706.5M | $405.8M | ||
| Q1 24 | $856.2M | $389.9M |
| Q4 25 | $2.2B | $765.0M | ||
| Q3 25 | $2.2B | $751.3M | ||
| Q2 25 | $2.1B | $722.9M | ||
| Q1 25 | $2.0B | $713.9M | ||
| Q4 24 | $2.2B | $665.5M | ||
| Q3 24 | $2.1B | $670.9M | ||
| Q2 24 | $2.0B | $657.8M | ||
| Q1 24 | $2.2B | $650.0M |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $-10.2M |
| Free Cash FlowOCF − Capex | — | $-13.3M |
| FCF MarginFCF / Revenue | — | -4.1% |
| Capex IntensityCapex / Revenue | — | 1.0% |
| Cash ConversionOCF / Net Profit | 3.39× | -0.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | $48.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $-10.2M | ||
| Q3 25 | $137.3M | $11.8M | ||
| Q2 25 | $137.2M | $12.6M | ||
| Q1 25 | $-117.5M | $45.1M | ||
| Q4 24 | $133.0M | $3.9M | ||
| Q3 24 | $91.8M | $9.1M | ||
| Q2 24 | $107.0M | $-24.7M | ||
| Q1 24 | $-125.2M | $38.4M |
| Q4 25 | — | $-13.3M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $10.4M | ||
| Q1 25 | — | $43.4M | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | — | $8.0M | ||
| Q2 24 | — | $-25.7M | ||
| Q1 24 | — | $36.7M |
| Q4 25 | — | -4.1% | ||
| Q3 25 | — | 2.5% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | 14.6% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 2.8% | ||
| Q2 24 | — | -9.1% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | 3.39× | -0.55× | ||
| Q3 25 | 1.91× | 0.56× | ||
| Q2 25 | 3.49× | 1.24× | ||
| Q1 25 | -5.66× | 3.82× | ||
| Q4 24 | 4.36× | 0.32× | ||
| Q3 24 | 4.72× | 0.83× | ||
| Q2 24 | — | -1.60× | ||
| Q1 24 | -31.03× | 3.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
RVLV
| Fashion Apparel | $155.1M | 48% |
| Dresses | $76.4M | 24% |
| Handbags Shoes And Accessories | $67.6M | 21% |
| Beauty | $20.3M | 6% |
| Manufactured Product Other | $5.0M | 2% |
| Breakage On Store Credit And Gift Cards | $900.0K | 0% |
